Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|11|1677-1685

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.11, 2014-06, pp. : 1677-1685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Front‐line, dose‐escalated immunochemotherapy is associated with a significant progression‐free survival advantage in patients with double‐hit lymphomas: a systematic review and meta‐analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 504-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 12, 2015-06 ,pp. : 2844-2853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low incidence of MYC/BCL2 double‐hit in Burkitt lymphoma

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 9, 2015-09 ,pp. : 486-489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potentially inappropriate medication use in elderly non‐Hodgkin lymphoma patients is associated with reduced survival and increased toxicities

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 2, 2018-01 ,pp. : 267-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoplasms and infections as the main causes of death in patients in complete response to HIV‐related non‐Hodgkin lymphoma in the combination antiretroviral therapy era: a study out of a series of 146 patients

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 289-291

John Wiley & Sons Inc

Access to resources Recommend Favorite